(Q30890584)

27 June 2017

1 reference

title

Attention-deficit/hyperactivity disorder in children and adolescents (English)

1 reference

attention deficit hyperactivity disorder

27 June 2017

main subject

1 reference

David W Dunn

1

1 reference

27 June 2017

William G Kronenberger

series ordinal

2

1 reference

27 June 2017

language of work or name

1 reference

1 November 2003

1 reference

27 June 2017

1 reference

27 June 2017

volume

21

1 reference

27 June 2017

issue

4

1 reference

27 June 2017

page(s)

933-940

1 reference

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Components of attention in children with complex partial seizures with and without ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Attention deficits and autistic spectrum problems in children exposed to alcohol during gestation: a follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Behavioral phenotypes of genetic syndromes: a reference guide for psychiatrists

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Annotation: tuberous sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

A twin study of the etiology of comorbidity: attention-deficit hyperactivity disorder and dyslexia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Association of the dopamine transporter gene (DAT1) with poor methylphenidate response

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Genetics of childhood disorders: XX. ADHD, Part 4: is ADHD genetically heterogeneous?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Genetics of childhood disorders: XVII. ADHD, Part 1: The executive functions and ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Evaluating attention deficit hyperactivity disorder using multiple informants: The incremental utility of combining teacher with parent reports

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Diagnostic efficiency of neuropsychological test scores for discriminating boys with and without attention deficit–hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Does the Conners' Continuous Performance Test aid in ADHD diagnosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Development of clinical services for attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2803%2900009-4

7 January 2021

10.1016/S0733-8619(03)00009-4

Identifiers

DOI

1 reference

27 June 2017

1 reference